These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 29084064)

  • 21. Structural brain network measures are superior to vascular burden scores in predicting early cognitive impairment in post stroke patients with small vessel disease.
    Du J; Wang Y; Zhi N; Geng J; Cao W; Yu L; Mi J; Zhou Y; Xu Q; Wen W; Sachdev P
    Neuroimage Clin; 2019; 22():101712. PubMed ID: 30772684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Texture Analysis of T1-Weighted and Fluid-Attenuated Inversion Recovery Images Detects Abnormalities That Correlate With Cognitive Decline in Small Vessel Disease.
    Tozer DJ; Zeestraten E; Lawrence AJ; Barrick TR; Markus HS
    Stroke; 2018 Jul; 49(7):1656-1661. PubMed ID: 29866751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional amyloid burden and lacune in pure subcortical vascular cognitive impairment.
    Hong YJ; Kim CM; Kim JE; Roh JH; Kim JS; Seo SW; Na DL; Lee JH
    Neurobiol Aging; 2017 Jul; 55():20-26. PubMed ID: 28395177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural network connectivity impairment and depressive symptoms in cerebral small vessel disease.
    Xie X; Shi Y; Zhang J
    J Affect Disord; 2017 Oct; 220():8-14. PubMed ID: 28575716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychiatric Correlates of Small Vessel Disease Progression in Incident Cognitive Decline: Independent and Interactive Effects.
    Kan CN; Gyanwali B; Hilal S; Ng KP; Venketasubramanian N; Chen CL; Xu X
    J Alzheimers Dis; 2020; 73(3):1053-1062. PubMed ID: 31884482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
    Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between total MRI-visible small vessel disease burden and domain-specific cognitive abilities in a community-dwelling older-age cohort.
    Hamilton O; Cox SR; Ballerini L; Bastin ME; Corley J; Gow AJ; Muñoz Maniega S; Redmond P; Valdés Hernández MDC; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2021 Sep; 105():25-34. PubMed ID: 34022536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.
    Altermatt A; Gaetano L; Magon S; Bauer L; Feurer R; Gnahn H; Hartmann J; Seifert CL; Poppert H; Wuerfel J; Radue EW; Kappos L; Sprenger T
    Neuroimage; 2019 Apr; 189():727-733. PubMed ID: 30685330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance imaging for assessment of cerebrovascular reactivity in cerebral small vessel disease: A systematic review.
    Blair GW; Doubal FN; Thrippleton MJ; Marshall I; Wardlaw JM
    J Cereb Blood Flow Metab; 2016 May; 36(5):833-41. PubMed ID: 26884471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroimaging in vascular cognitive impairment: a state-of-the-art review.
    Heiss WD; Rosenberg GA; Thiel A; Berlot R; de Reuck J
    BMC Med; 2016 Nov; 14(1):174. PubMed ID: 27806705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lesion location and cognitive impact of cerebral small vessel disease.
    Biesbroek JM; Weaver NA; Biessels GJ
    Clin Sci (Lond); 2017 Apr; 131(8):715-728. PubMed ID: 28385827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors Associated With 8-Year Mortality in Older Patients With Cerebral Small Vessel Disease: The Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study.
    van der Holst HM; van Uden IW; Tuladhar AM; de Laat KF; van Norden AG; Norris DG; van Dijk EJ; Rutten-Jacobs LC; de Leeuw FE
    JAMA Neurol; 2016 Apr; 73(4):402-9. PubMed ID: 26831360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of dementia using diffusion tensor MRI measures: the OPTIMAL collaboration.
    Egle M; Hilal S; Tuladhar AM; Pirpamer L; Hofer E; Duering M; Wason J; Morris RG; Dichgans M; Schmidt R; Tozer D; Chen C; de Leeuw FE; Markus HS
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):14-23. PubMed ID: 34509999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of amyloid and small vessel disease on white matter network disruption.
    Kim HJ; Im K; Kwon H; Lee JM; Ye BS; Kim YJ; Cho H; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2015; 44(3):963-75. PubMed ID: 25374100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of rich club organisation in cerebral small vessel disease.
    Tuladhar AM; Lawrence A; Norris DG; Barrick TR; Markus HS; de Leeuw FE
    Hum Brain Mapp; 2017 Apr; 38(4):1751-1766. PubMed ID: 27935154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrovascular Reactivity in Patients With Small Vessel Disease: A Cross-Sectional Study.
    Sleight E; Stringer MS; Clancy U; Arteaga C; Jaime Garcia D; Hewins W; Jochems ACC; Hamilton OKL; Manning C; Morgan AG; Locherty R; Cheng Y; Liu X; Zhang J; Hamilton I; Jardine C; Brown R; Sakka E; Kampaite A; Wiseman S; Valdés-Hernández MC; Chappell FM; Doubal FN; Marshall I; Thrippleton MJ; Wardlaw JM
    Stroke; 2023 Nov; 54(11):2776-2784. PubMed ID: 37814956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune regulation and blood-brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study - a multicentre prospective cohort study.
    Low A; van Winden S; Cai L; Kessels RPC; Maas MC; Morris RG; Nus M; Tozer DJ; Tuladhar A; van der Kolk A; Wolters R; Mallat Z; Riksen NP; Markus H; de Leeuw FE
    BMJ Open; 2024 Feb; 14(2):e084303. PubMed ID: 38413153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural network connectivity and cognition in cerebral small vessel disease.
    Tuladhar AM; van Dijk E; Zwiers MP; van Norden AG; de Laat KF; Shumskaya E; Norris DG; de Leeuw FE
    Hum Brain Mapp; 2016 Jan; 37(1):300-10. PubMed ID: 26466741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.
    Dickie DA; Quinn TJ; Dawson J
    Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rich-Club Analysis of the Structural Brain Network in Cases with Cerebral Small Vessel Disease and Depression Symptoms.
    Lu Y; Li Y; Feng Q; Shen R; Zhu H; Zhou H; Zhao Z
    Cerebrovasc Dis; 2022; 51(1):92-101. PubMed ID: 34537766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.